20/20 Biolabs, Inc.
AIDX- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- SEC CIK
- 0001139685
No open-market purchases or sales by 20/20 Biolabs, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $297.1K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +8 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $297.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AIDX, Q2 2026
No superinvestor reported holding AIDX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by 20/20 Biolabs, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by 20/20 Biolabs, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in 20/20 Biolabs, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cresset Asset Management, LLC | 240,122 | $132.0K | 0.00% | −24,246−9.2% | Reduced |
| HRT Financial LP | 89,273 | $49.0K | 0.00% | +89,273 | New |
| Vanguard Fiduciary Trust Co | 52,087 | $28.6K | 0.00% | +52,087 | New |
| Geode Capital Management, LLC | 49,141 | $27.0K | 0.00% | +49,141 | New |
| Atlantic Union Bankshares Corp | 35,099 | $19.3K | 0.00% | +35,099 | New |
| Vanguard Capital Management LLC | 24,530 | $13.5K | 0.00% | +24,530 | New |
| Citadel Advisors LLC | 23,205 | $12.8K | 0.00% | +6,978+43.0% | Added |
| Bank of America Corp | 13,024 | $7.15K | 0.00% | +13,024 | New |
| Susquehanna International Group, LLP | 10,014 | $5.50K | 0.00% | +10,014 | New |
| McDonald Partners LLC | 2,800 | $1.54K | 0.00% | +2,800 | New |